The oversubscription of India Life Sciences Fund II shows that investors are open to funds offering focused expertise in certain key indust...

This is a tough environment to be a banker of any sort. While many in the business are still wondering what the future holds, five ex-banke...

As risk capital flow for biotechnology start-ups in India picks up, entrepreneurs are now seeking greater support in policy, intellectual p...